TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group.

David Ebb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.